Device type · JMO
Ferrozine (Colorimetric) Iron Binding Capacity
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
JMO
Clinical Chemistry
Device class
Class I
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Ferrozine (Colorimetric) Iron Binding Capacity
- Product code
- JMO
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1415
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for JMO
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- UIBC (Unsaturated Iron Binding Capacity), REF: OSR61205,Open, Classified
Z-2264-2025 · Started Jun 26, 2025 · Posted by FDA Aug 4, 2025
Reason given: Beckman Coulter identified that the Unsaturated Iron Binding Capacity (UIBC) assay is not meeting their labeled hemoglobin interference claims of no significant interference (i.e., less than 10%) up to 200 mg/dL hemoglobin as indicated in their instructions for use. Initial internal testing confirmed that samples with...
Cause as FDA categorized it: Process design
Ortho-Clinical Diagnostics, Inc.
Z-2245-2024 · Started May 14, 2024 · Posted by FDA Jul 1, 2024
Reason given: Kit assigned an extended expiration date of 24-Jul-2025 during release. The correct expiration date for Lot 2953 is 24-Jul-2024. If used past its true expiration and the customer does not have their Assay Data Disk (ADD) updated, the system will allow them to use the expired calibrator which may bias the results....
Cause as FDA categorized it: Labeling design
Z-3028-2020 · Started Aug 18, 2020
Reason given: The manufacturer has identified that the use of Unsaturated Iron Binding Capacity (UBIC) lot 2690 will produce erroneously high patient results at the low end of the linear range.
Cause as FDA categorized it: Under Investigation by firm
4 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.